Loading...

Antibodies to watch in 2010

Monoclonal antibodies (mAbs) are a burgeoning class of therapeutics, with more than 25 approved in countries worldwide. Novel molecules are entering clinical study at a rate of nearly 40 per year, and the commercial pipeline includes approximately 240 mAb therapeutics in clinical studies that have n...

Full description

Saved in:
Bibliographic Details
Main Author: Reichert, Janice M
Format: Artigo
Language:Inglês
Published: Landes Bioscience 2010
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828582/
https://ncbi.nlm.nih.gov/pubmed/20065640
Tags: Add Tag
No Tags, Be the first to tag this record!